APO Research

APO RESEARCH · REPORT

Livestock Animal Vaccines

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether.

Product & engineering

Understand the product.

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether.

Selected research

Market Structure

Global Livestock Animal Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether.

There are three kinds of Livestock Animal Vaccine, which are Live Attenuated Vaccines, Inactivated Vaccines and others. Live attenuated vaccines hold the largest share of the Livestock Animal Vaccines market, with a sales market share nearly 53.75% in 2019. Livestock Animal Vaccine is use in Pig, Cattle, Poultry and Other. The most proportion of Livestock Animal Vaccine is used in Cattle, and the market share in 2019 is about 34.73% and the proportion of Pigs in 2019 is about 23.35%. Market competition is intense; Merck, Zoetis, Boehringer Ingelheim, Ceva, etc. are the leader of the industry, and top 5 players hold about 70.27% revenue market share, with high-end customers.

This report provides an overview of the global Livestock Animal Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Livestock Animal Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Livestock Animal Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Livestock Animal Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Livestock Animal Vaccines Segment by Company

Merck

Boehringer Ingelheim

Zoetis

Ceva

Elanco

CAHIC

Jinyu Bio-Technology

HVRI

Ringpu Biology

Yebio

DHN

Kyoto Biken Laboratories

WINSUN

FATRO

CAVAC

MEVAC

Biovac

ChengDu Tecbond

Vaksindo

Bio-Labs

Livestock Animal Vaccines Segment by Type

Live Attenuated Vaccine

Inactivated Vaccine

Other Vaccines

Livestock Animal Vaccines Segment by Application

Pig

Cattle

Poultry

Others

Livestock Animal Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Livestock Animal Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Livestock Animal Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Livestock Animal Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Livestock Animal Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Livestock Animal Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Livestock Animal Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Livestock Animal Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Livestock Animal Vaccines Industry Trends Table 2. Livestock Animal Vaccines Industry Drivers Table 3. Livestock Animal Vaccines Industry Opportunities and Challenges Table 4. Livestock Animal Vaccines Industry Restraints Table 5. Global Livestock Animal Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Livestock Animal Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Livestock Animal Vaccines Sales by Manufacturers (M Doses) & (2021-2026) Table 8. Global Livestock Animal Vaccines Sales Market Share by Manufacturers Table 9. Global Livestock Animal Vaccines Average Sales Price (USD/K Doses) of Manufacturers (2021-2026) Table 10. Global Livestock Animal Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Livestock Animal Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Livestock Animal Vaccines Manufacturers, Product Type & Application Table 13. Global Livestock Animal Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Livestock Animal Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Live Attenuated Vaccine Table 17. Major Manufacturers of Inactivated Vaccine Table 18. Major Manufacturers of Other Vaccines Table 19. Global Livestock Animal Vaccines Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 20. Global Livestock Animal Vaccines Sales by Type (2021-2026) & (M Doses) Table 21. Global Livestock Animal Vaccines Sales by Type (2027-2032) & (M Doses) Table 22. Global Livestock Animal Vaccines Sales Market Share by Type (2021-2026) Table 23. Global Livestock Animal Vaccines Sales Market Share by Type (2027-2032) Table 24. Global Livestock Animal Vaccines Revenue by Type 2021 VS 2025 VS 2032 (M Doses) Table 25. Global Livestock Animal Vaccines Revenue by Type (2021-2026) & (M Doses) Table 26. Global Livestock Animal Vaccines Revenue by Type (2027-2032) & (M Doses) Table 27. Global Livestock Animal Vaccines Revenue Market Share by Type (2021-2026) Table 28. Global Livestock Animal Vaccines Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Pig Table 30. Major Manufacturers of Cattle Table 31. Major Manufacturers of Poultry Table 32. Major Manufacturers of Others Table 33. Global Livestock Animal Vaccines Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 34. Global Livestock Animal Vaccines Sales by Application (2021-2026) & (M Doses) Table 35. Global Livestock Animal Vaccines Sales by Application (2027-2032) & (M Doses) Table 36. Global Livestock Animal Vaccines Sales Market Share by Application (2021-2026) Table 37. Global Livestock Animal Vaccines Sales Market Share by Application (2027-2032) Table 38. Global Livestock Animal Vaccines Revenue by Application 2021 VS 2025 VS 2032 (M Doses) Table 39. Global Livestock Animal Vaccines Revenue by Application (2021-2026) & (M Doses) Table 40. Global Livestock Animal Vaccines Revenue by Application (2027-2032) & (M Doses) Table 41. Global Livestock Animal Vaccines Revenue Market Share by Application (2021-2026) Table 42. Global Livestock Animal Vaccines Revenue Market Share by Application (2027-2032) Table 43. Global Livestock Animal Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Table 44. Global Livestock Animal Vaccines Sales by Region (2021-2026) & (M Doses) Table 45. Global Livestock Animal Vaccines Sales Market Share by Region (2021-2026) Table 46. Global Livestock Animal Vaccines Sales Forecasted by Region (2027-2032) & (M Doses) Table 47. Global Livestock Animal Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Livestock Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 49. North America Livestock Animal Vaccines Sales by Country (2021-2026) & (M Doses) Table 50. North America Livestock Animal Vaccines Sales by Country (2027-2032) & (M Doses) Table 51. Europe Livestock Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 52. Europe Livestock Animal Vaccines Sales by Country (2021-2026) & (M Doses) Table 53. Europe Livestock Animal Vaccines Sales by Country (2027-2032) & (M Doses) Table 54. Asia Pacific Livestock Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 55. Asia Pacific Livestock Animal Vaccines Sales by Country (2021-2026) & (M Doses) Table 56. Asia Pacific Livestock Animal Vaccines Sales by Country (2027-2032) & (M Doses) Table 57. South America, Middle East and Africa Livestock Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 58. South America, Middle East and Africa Livestock Animal Vaccines Sales by Country (2021-2026) & (M Doses) Table 59. South America, Middle East and Africa Livestock Animal Vaccines Sales by Country (2027-2032) & (M Doses) Table 60. Global Livestock Animal Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Livestock Animal Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Livestock Animal Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Livestock Animal Vaccines Revenue Market Share by Region (2021-2026) Table 64. Global Livestock Animal Vaccines Revenue Market Share by Region (2027-2032) Table 65. Merck Company Information Table 66. Merck Business Overview Table 67. Merck Livestock Animal Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Merck Livestock Animal Vaccines Product Portfolio Table 69. Merck Recent Development Table 70. Boehringer Ingelheim Company Information Table 71. Boehringer Ingelheim Business Overview Table 72. Boehringer Ingelheim Livestock Animal Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Boehringer Ingelheim Livestock Animal Vaccines Product Portfolio Table 74. Boehringer Ingelheim Recent Development Table 75. Zoetis Company Information Table 76. Zoetis Business Overview Table 77. Zoetis Livestock Animal Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Zoetis Livestock Animal Vaccines Product Portfolio Table 79. Zoetis Recent Development Table 80. Ceva Company Information Table 81. Ceva Business Overview Table 82. Ceva Livestock Animal Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Ceva Livestock Animal Vaccines Product Portfolio Table 84. Ceva Recent Development Table 85. Elanco Company Information Table 86. Elanco Business Overview Table 87. Elanco Livestock Animal Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Elanco Livestock Animal Vaccines Product Portfolio Table 89. Elanco Recent Development Table 90. CAHIC Company Information Table 91. CAHIC Business Overview Table 92. CAHIC Livestock Animal Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. CAHIC Livestock Animal Vaccines Product Portfolio Table 94. CAHIC Recent Development Table 95. Jinyu Bio-Technology Company Information Table 96. Jinyu Bio-Technology Business Overview Table 97. Jinyu Bio-Technology Livestock Animal Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Jinyu Bio-Technology Livestock Animal Vaccines Product Portfolio Table 99. Jinyu Bio-Technology Recent Development Table 100. HVRI Company Information Table 101. HVRI Business Overview Table 102. HVRI Livestock Animal Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. HVRI Livestock Animal Vaccines Product Portfolio Table 104. HVRI Recent Development Table 105. Ringpu Biology Company Information Table 106. Ringpu Biology Business Overview Table 107. Ringpu Biology Livestock Animal Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Ringpu Biology Livestock Animal Vaccines Product Portfolio Table 109. Ringpu Biology Recent Development Table 110. Yebio Company Information Table 111. Yebio Business Overview Table 112. Yebio Livestock Animal Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Yebio Livestock Animal Vaccines Product Portfolio Table 114. Yebio Recent Development Table 115. DHN Company Information Table 116. DHN Business Overview Table 117. DHN Livestock Animal Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. DHN Livestock Animal Vaccines Product Portfolio Table 119. DHN Recent Development Table 120. Kyoto Biken Laboratories Company Information Table 121. Kyoto Biken Laboratories Business Overview Table 122. Kyoto Biken Laboratories Livestock Animal Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Kyoto Biken Laboratories Livestock Animal Vaccines Product Portfolio Table 124. Kyoto Biken Laboratories Recent Development Table 125. WINSUN Company Information Table 126. WINSUN Business Overview Table 127. WINSUN Livestock Animal Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. WINSUN Livestock Animal Vaccines Product Portfolio Table 129. WINSUN Recent Development Table 130. FATRO Company Information Table 131. FATRO Business Overview Table 132. FATRO Livestock Animal Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. FATRO Livestock Animal Vaccines Product Portfolio Table 134. FATRO Recent Development Table 135. CAVAC Company Information Table 136. CAVAC Business Overview Table 137. CAVAC Livestock Animal Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. CAVAC Livestock Animal Vaccines Product Portfolio Table 139. CAVAC Recent Development Table 140. MEVAC Company Information Table 141. MEVAC Business Overview Table 142. MEVAC Livestock Animal Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. MEVAC Livestock Animal Vaccines Product Portfolio Table 144. MEVAC Recent Development Table 145. Biovac Company Information Table 146. Biovac Business Overview Table 147. Biovac Livestock Animal Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Biovac Livestock Animal Vaccines Product Portfolio Table 149. Biovac Recent Development Table 150. ChengDu Tecbond Company Information Table 151. ChengDu Tecbond Business Overview Table 152. ChengDu Tecbond Livestock Animal Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. ChengDu Tecbond Livestock Animal Vaccines Product Portfolio Table 154. ChengDu Tecbond Recent Development Table 155. Vaksindo Company Information Table 156. Vaksindo Business Overview Table 157. Vaksindo Livestock Animal Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 158. Vaksindo Livestock Animal Vaccines Product Portfolio Table 159. Vaksindo Recent Development Table 160. Bio-Labs Company Information Table 161. Bio-Labs Business Overview Table 162. Bio-Labs Livestock Animal Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 163. Bio-Labs Livestock Animal Vaccines Product Portfolio Table 164. Bio-Labs Recent Development Table 165. Key Raw Materials Table 166. Raw Materials Key Suppliers Table 167. Livestock Animal Vaccines Distributors List Table 168. Livestock Animal Vaccines Customers List Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Livestock Animal Vaccines Product Image Figure 2. Global Livestock Animal Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Livestock Animal Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Livestock Animal Vaccines Sales (2021-2032) & (M Doses) Figure 5. Global Livestock Animal Vaccines Average Price (USD/K Doses) & (2021-2032) Figure 6. Global Top 5 and 10 Livestock Animal Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Live Attenuated Vaccine Image Figure 9. Inactivated Vaccine Image Figure 10. Other Vaccines Image Figure 11. Global Livestock Animal Vaccines Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 12. Global Livestock Animal Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Livestock Animal Vaccines Sales Market Share by Type (2021-2032) Figure 14. Global Livestock Animal Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 15. Global Livestock Animal Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Livestock Animal Vaccines Revenue Market Share by Type (2021-2032) Figure 17. Pig Image Figure 18. Cattle Image Figure 19. Poultry Image Figure 20. Others Image Figure 21. Global Livestock Animal Vaccines Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 22. Global Livestock Animal Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Livestock Animal Vaccines Sales Market Share by Application (2021-2032) Figure 24. Global Livestock Animal Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 25. Global Livestock Animal Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Livestock Animal Vaccines Revenue Market Share by Application (2021-2032) Figure 27. North America Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 28. North America Livestock Animal Vaccines Sales Market Share by Country (2021-2032) Figure 29. U.S. Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 30. Canada Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 31. Mexico Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 32. Europe Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 33. Europe Livestock Animal Vaccines Sales Market Share by Country (2021-2032) Figure 34. Germany Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 35. France Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 36. U.K. Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 37. Italy Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 38. Netherlands Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 39. Asia Pacific Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 40. Asia Pacific Livestock Animal Vaccines Sales Market Share by Country (2021-2032) Figure 41. China Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 42. Japan Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 43. South Korea Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 44. Southeast Asia Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 45. India Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 46. Australia Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 47. South America, Middle East and Africa Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 48. South America, Middle East and Africa Livestock Animal Vaccines Sales Market Share by Country (2021-2032) Figure 49. Brazil Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 50. South Africa Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 51. Saudi Arabia Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 52. Turkey Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 53. Argentina Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 54. UAE Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 55. Egypt Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 56. Chile Livestock Animal Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 57. Global Livestock Animal Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Livestock Animal Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Livestock Animal Vaccines Revenue (2021-2032) & (US$ Million) Figure 60. North America Livestock Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Livestock Animal Vaccines Revenue (2021-2032) & (US$ Million) Figure 62. Europe Livestock Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Livestock Animal Vaccines Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Livestock Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Livestock Animal Vaccines Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Livestock Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Livestock Animal Vaccines Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Livestock Animal Vaccines Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Live Attenuated Vaccine
  • Inactivated Vaccine
  • Other Vaccines
Applications
  • Pig
  • Cattle
  • Poultry
  • Others
Companies covered
  • Merck
  • Boehringer Ingelheim
  • Zoetis
  • Ceva
  • Elanco
  • CAHIC
  • Jinyu Bio-Technology
  • HVRI
  • Ringpu Biology
  • Yebio
  • DHN
  • Kyoto Biken Laboratories
  • WINSUN
  • FATRO
  • CAVAC
  • MEVAC
  • Biovac
  • ChengDu Tecbond
  • Vaksindo
  • Bio-Labs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Livestock Animal Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Livestock Animal Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Livestock Animal Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Livestock Animal Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Livestock Animal Vaccines Market Dynamics
  1. 2.1 Livestock Animal Vaccines Industry Trends
  2. 2.2 Livestock Animal Vaccines Industry Drivers
  3. 2.3 Livestock Animal Vaccines Industry Opportunities and Challenges
  4. 2.4 Livestock Animal Vaccines Industry Restraints
3 Livestock Animal Vaccines Market by Manufacturers
  1. 3.1 Global Livestock Animal Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Livestock Animal Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Livestock Animal Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Livestock Animal Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Livestock Animal Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Livestock Animal Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Livestock Animal Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Livestock Animal Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Livestock Animal Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Livestock Animal Vaccines Tier 1, Tier 2, and Tier 3
4 Livestock Animal Vaccines Market by Type
  1. 4.1 Livestock Animal Vaccines Type Introduction
  2. 4.1.1 Live Attenuated Vaccine
  3. 4.1.2 Inactivated Vaccine
  4. 4.1.3 Other Vaccines
  5. 4.2 Global Livestock Animal Vaccines Sales by Type
  6. 4.2.1 Global Livestock Animal Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Livestock Animal Vaccines Sales by Type (2021-2032)
  8. 4.2.3 Global Livestock Animal Vaccines Sales Market Share by Type (2021-2032)
  9. 4.3 Global Livestock Animal Vaccines Revenue by Type
  10. 4.3.1 Global Livestock Animal Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Livestock Animal Vaccines Revenue by Type (2021-2032)
  12. 4.3.3 Global Livestock Animal Vaccines Revenue Market Share by Type (2021-2032)
5 Livestock Animal Vaccines Market by Application
  1. 5.1 Livestock Animal Vaccines Application Introduction
  2. 5.1.1 Pig
  3. 5.1.2 Cattle
  4. 5.1.3 Poultry
  5. 5.1.4 Others
  6. 5.2 Global Livestock Animal Vaccines Sales by Application
  7. 5.2.1 Global Livestock Animal Vaccines Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Livestock Animal Vaccines Sales by Application (2021-2032)
  9. 5.2.3 Global Livestock Animal Vaccines Sales Market Share by Application (2021-2032)
  10. 5.3 Global Livestock Animal Vaccines Revenue by Application
  11. 5.3.1 Global Livestock Animal Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Livestock Animal Vaccines Revenue by Application (2021-2032)
  13. 5.3.3 Global Livestock Animal Vaccines Revenue Market Share by Application (2021-2032)
6 Global Livestock Animal Vaccines Sales by Region
  1. 6.1 Global Livestock Animal Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Livestock Animal Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Livestock Animal Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Livestock Animal Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Livestock Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Livestock Animal Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Livestock Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Livestock Animal Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Livestock Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Livestock Animal Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Livestock Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Livestock Animal Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Livestock Animal Vaccines Revenue by Region
  1. 7.1 Global Livestock Animal Vaccines Revenue by Region
  2. 7.1.1 Global Livestock Animal Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Livestock Animal Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Livestock Animal Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Livestock Animal Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Livestock Animal Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Livestock Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Livestock Animal Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Livestock Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Livestock Animal Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Livestock Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Livestock Animal Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Livestock Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Livestock Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Livestock Animal Vaccines Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Boehringer Ingelheim
  8. 8.2.1 Boehringer Ingelheim Company Information
  9. 8.2.2 Boehringer Ingelheim Business Overview
  10. 8.2.3 Boehringer Ingelheim Livestock Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim Livestock Animal Vaccines Product Portfolio
  12. 8.2.5 Boehringer Ingelheim Recent Developments
  13. 8.3 Zoetis
  14. 8.3.1 Zoetis Company Information
  15. 8.3.2 Zoetis Business Overview
  16. 8.3.3 Zoetis Livestock Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Zoetis Livestock Animal Vaccines Product Portfolio
  18. 8.3.5 Zoetis Recent Developments
  19. 8.4 Ceva
  20. 8.4.1 Ceva Company Information
  21. 8.4.2 Ceva Business Overview
  22. 8.4.3 Ceva Livestock Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ceva Livestock Animal Vaccines Product Portfolio
  24. 8.4.5 Ceva Recent Developments
  25. 8.5 Elanco
  26. 8.5.1 Elanco Company Information
  27. 8.5.2 Elanco Business Overview
  28. 8.5.3 Elanco Livestock Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Elanco Livestock Animal Vaccines Product Portfolio
  30. 8.5.5 Elanco Recent Developments
  31. 8.6 CAHIC
  32. 8.6.1 CAHIC Company Information
  33. 8.6.2 CAHIC Business Overview
  34. 8.6.3 CAHIC Livestock Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 CAHIC Livestock Animal Vaccines Product Portfolio
  36. 8.6.5 CAHIC Recent Developments
  37. 8.7 Jinyu Bio-Technology
  38. 8.7.1 Jinyu Bio-Technology Company Information
  39. 8.7.2 Jinyu Bio-Technology Business Overview
  40. 8.7.3 Jinyu Bio-Technology Livestock Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jinyu Bio-Technology Livestock Animal Vaccines Product Portfolio
  42. 8.7.5 Jinyu Bio-Technology Recent Developments
  43. 8.8 HVRI
  44. 8.8.1 HVRI Company Information
  45. 8.8.2 HVRI Business Overview
  46. 8.8.3 HVRI Livestock Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 HVRI Livestock Animal Vaccines Product Portfolio
  48. 8.8.5 HVRI Recent Developments
  49. 8.9 Ringpu Biology
  50. 8.9.1 Ringpu Biology Company Information
  51. 8.9.2 Ringpu Biology Business Overview
  52. 8.9.3 Ringpu Biology Livestock Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ringpu Biology Livestock Animal Vaccines Product Portfolio
  54. 8.9.5 Ringpu Biology Recent Developments
  55. 8.10 Yebio
  56. 8.10.1 Yebio Company Information
  57. 8.10.2 Yebio Business Overview
  58. 8.10.3 Yebio Livestock Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Yebio Livestock Animal Vaccines Product Portfolio
  60. 8.10.5 Yebio Recent Developments
  61. 8.11 DHN
  62. 8.11.1 DHN Company Information
  63. 8.11.2 DHN Business Overview
  64. 8.11.3 DHN Livestock Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 DHN Livestock Animal Vaccines Product Portfolio
  66. 8.11.5 DHN Recent Developments
  67. 8.12 Kyoto Biken Laboratories
  68. 8.12.1 Kyoto Biken Laboratories Company Information
  69. 8.12.2 Kyoto Biken Laboratories Business Overview
  70. 8.12.3 Kyoto Biken Laboratories Livestock Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Kyoto Biken Laboratories Livestock Animal Vaccines Product Portfolio
  72. 8.12.5 Kyoto Biken Laboratories Recent Developments
  73. 8.13 WINSUN
  74. 8.13.1 WINSUN Company Information
  75. 8.13.2 WINSUN Business Overview
  76. 8.13.3 WINSUN Livestock Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 WINSUN Livestock Animal Vaccines Product Portfolio
  78. 8.13.5 WINSUN Recent Developments
  79. 8.14 FATRO
  80. 8.14.1 FATRO Company Information
  81. 8.14.2 FATRO Business Overview
  82. 8.14.3 FATRO Livestock Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 FATRO Livestock Animal Vaccines Product Portfolio
  84. 8.14.5 FATRO Recent Developments
  85. 8.15 CAVAC
  86. 8.15.1 CAVAC Company Information
  87. 8.15.2 CAVAC Business Overview
  88. 8.15.3 CAVAC Livestock Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CAVAC Livestock Animal Vaccines Product Portfolio
  90. 8.15.5 CAVAC Recent Developments
  91. 8.16 MEVAC
  92. 8.16.1 MEVAC Company Information
  93. 8.16.2 MEVAC Business Overview
  94. 8.16.3 MEVAC Livestock Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 MEVAC Livestock Animal Vaccines Product Portfolio
  96. 8.16.5 MEVAC Recent Developments
  97. 8.17 Biovac
  98. 8.17.1 Biovac Company Information
  99. 8.17.2 Biovac Business Overview
  100. 8.17.3 Biovac Livestock Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Biovac Livestock Animal Vaccines Product Portfolio
  102. 8.17.5 Biovac Recent Developments
  103. 8.18 ChengDu Tecbond
  104. 8.18.1 ChengDu Tecbond Company Information
  105. 8.18.2 ChengDu Tecbond Business Overview
  106. 8.18.3 ChengDu Tecbond Livestock Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 ChengDu Tecbond Livestock Animal Vaccines Product Portfolio
  108. 8.18.5 ChengDu Tecbond Recent Developments
  109. 8.19 Vaksindo
  110. 8.19.1 Vaksindo Company Information
  111. 8.19.2 Vaksindo Business Overview
  112. 8.19.3 Vaksindo Livestock Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Vaksindo Livestock Animal Vaccines Product Portfolio
  114. 8.19.5 Vaksindo Recent Developments
  115. 8.20 Bio-Labs
  116. 8.20.1 Bio-Labs Company Information
  117. 8.20.2 Bio-Labs Business Overview
  118. 8.20.3 Bio-Labs Livestock Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Bio-Labs Livestock Animal Vaccines Product Portfolio
  120. 8.20.5 Bio-Labs Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Livestock Animal Vaccines Value Chain Analysis
  2. 9.1.1 Livestock Animal Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Livestock Animal Vaccines Production Mode & Process
  6. 9.2 Livestock Animal Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Livestock Animal Vaccines Distributors
  9. 9.2.3 Livestock Animal Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research